Abstract
This chapter describes the PDD Behavior Inventory (PDDBI) and PDD Behavior Inventory-Screening Version (PDDBI-SV) which are relatively new informant-based rating scales useful clinically and for research studies. The information gathered from the PDDBI is unique in that it provides dimensional assessment of both problem behaviors and adaptive skills. Further, the scores that are derived are standardized on children with autism spectrum disorder (ASD) and take age into account. This enables the clinician or researcher to ascertain, for an individual case, whether scores are typical or atypically low or high for a child with ASD thereby facilitating identification of possible comorbid problems. The clinical applicability of the PDDBI and the importance of the behavior profiles revealed by this assessment instrument are described first using four case vignettes. This is followed by description of the role of the PDDBI in research using, as an example, a study which identified clinical subtypes of boys with ASD based on their and their mother’s monoamine oxidase A (MAOA) genotype. Finally, the new PDDBI-SV, a rapid screening tool for ASD which was published in 2011, is described along with issues involved in screening rare disorders. It was concluded that the PDDBI and PDDBI-SV are assessment tools that provide important information not usually found with other measures.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adams JB, Audhya T, McDonough-Means S, et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab (Lond). 2011;8(1):34.
Allen DA. Autistic spectrum disorders: clinical presentation in preschool children. J Child Neurol. 1988;3(Suppl):S48–56.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth edition text revision. Washington, DC; 2000.
Autism and Developmental Disabilities Monitoring Network, United States. Prevalence of autism spectrum disorders, 2006. MMWR Surveill Summ. 2009;58(10):1–20.
Bent S, Bertoglio K, Ashwood P, Nemeth E, Hendren RL. Brief report: hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: a clinical trial. J Autism Dev Disord. 2012;42(6):1127–32.
Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993;262(5133):578–80.
Buckholtz JW, Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci. 2008;31(3):120–9.
Caspi A, McClay J, Moffitt TE, et al. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297(5582):851–4.
Cerasa A, Gioia MC, Fera F, et al. Ventro-lateral prefrontal activity during working memory is modulated by MAO A genetic variation. Brain Res. 2008;1201:114–21.
Chauhan A, Chauhan V, Brown WT, Cohen IL. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin – the antioxidant proteins. Life Sci. 2004;75:2539–49.
Cohen IL. Criterion-related validity of the PDD behavior inventory. J Autism Dev Disord. 2003;33(1):47–53.
Cohen IL. PDD behavior inventory screening version professional manual. Lutz: Psychological Assessment Resources; 2011.
Cohen IL, Sudhalter V. The PDD behavior inventory. Lutz: Psychological Assessment Resources; 2005a.
Cohen IL, Sudhalter V. PDD behavior inventory professional manual. Lutz: Psychological Assessment Resources; 2005b.
Cohen IL, Tsiouris J. Maternal recurrent mood disorders and high-functioning autism. J Autism Dev Disord. 2006;36:1077–8.
Cohen IL, Fisch GS, Sudhalter V, et al. Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard. 1988;92(5):436–46.
Cohen IL, Brown WT, Jenkins EC, et al. Fragile X syndrome in females with autism. Am J Med Genet. 1989a;34(2):302–3.
Cohen IL, Vietze PM, Sudhalter V, Jenkins EC, Brown WT. Parent-child dyadic gaze patterns in fragile X males and in non-fragile X males with autistic disorder. J Child Psychol Psychiatry. 1989b;30(6):845–56.
Cohen IL, Sudhalter V, Pfadt A, Jenkins EC, Brown WT, Vietze PM. Why are autism and the fragile-X syndrome associated? Conceptual and methodological issues. Am J Hum Genet. 1991a;48(2):195–202.
Cohen IL, Vietze PM, Sudhalter V, Jenkins EC, Brown WT. Effects of age and communication level on eye contact in fragile X males and non-fragile X autistic males. Am J Med Genet. 1991b;38(2–3):498–502.
Cohen IL, Nolin SL, Sudhalter V, Ding XH, Dobkin CS, Brown WT. Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males. Am J Med Genet. 1996;64(2):365–9.
Cohen IL, Liu X, Schutz C, et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet. 2003a;64:190–7.
Cohen IL, Schmidt-Lackner S, Romanczyk R, Sudhalter V. The PDD behavior inventory: a rating scale for assessing response to intervention in children with PDD. J Autism Dev Disord. 2003b;33(1):31–45.
Cohen IL, Gomez TR, Gonzalez MG, Lennon EM, Karmel BZ, Gardner JM. Parent PDD behavior inventory profiles of young children classified according to autism diagnostic observation schedule-generic and autism diagnostic interview-revised criteria. J Autism Dev Disord. 2010a;40(2):246–54.
Cohen IL, Liu X, Lewis ME, et al. Autism severity is associated with child and maternal MAOA genotypes. Clin Genet. 2010b;79(4):355–62.
Coleman M, Gillberg C. The autisms. New York: Oxford University Press; 2012.
Constantino JN, Davis SA, Todd RD, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4):427–33.
Cote F, Fligny C, Bayard E, et al. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci USA. 2007;104(1):329–34.
Croen LA, Najjar DV, Ray GT, Lotspeich L, Bernal P. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan. Pediatrics. 2006;118(4):e1203–11.
Davis LK, Hazlett HC, Librant AL, et al. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1145–51. 5 Oct 2008.
Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125(1):e17–23.
Deckert J, Catalano M, Syagailo YV, et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet. 1999;8(4):621–4.
Denney RM, Koch H, Craig IW. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat. Hum Genet. 1999;105:542–51.
Du L, Bakish D, Ravindran A, Hrdina PD. MAO-A gene polymorphisms are associated with major depression and sleep disturbance in males. Neuroreport. 2004;15(13):2097–101.
Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the quality standards subcommittee of the American academy of neurology and the child neurology society. Neurology. 2000;55(4):468–79.
Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009;39(5):693–705.
Green DM, Swets JA. Signal detection theory and psychophysics. New York: Wiley; 1966.
Happe F, Ronald A. The ‘fractionable autism triad’: a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev. 2008;18:287–304.
Herman AI, Kaiss KM, Ma R, et al. Serotonin transporter promoter polymorphism and monoamine oxidase type A VNTR allelic variants together influence alcohol binge drinking risk in young women. Am J Med Genet B Neuropsychiatr Genet. 2005;133B(1):74–8.
Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120(5):1183–215.
Karmel BZ, Gardner JM, Meade LS, et al. Early medical and behavioral characteristics of NICU infants later classified with ASD. Pediatrics. 2010;126(3):457–67.
Kim J, Wigram T, Gold C. The effects of improvisational music therapy on joint attention behaviors in autistic children: a randomized controlled study. J Autism Dev Disord. 2008;38(9):1758–66.
Komoto J, Usui S, Otsuki S, Terao A. Infantile autism and Duchenne muscular dystrophy. J Autism Dev Disord. 1984;14(2):191–5.
Liu X, Malenfant P, Reesor C, et al. 2p15-p16.1 microdeletion syndrome: molecular characterization and association of the OTX1 and XPO1 genes with autism spectrum disorders. Eur J Hum Genet. 2011;19(12):1264–70.
Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659–85.
Lord C, Rutter M, DiLavore PC, Risi S. Autism diagnostic observation schedule (ADOS). Los Angeles: Western Psychological Services; 1999. Manual ed.
Malenfant P, Liu X, Hudson ML, et al. Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders. J Autism Dev Disord. 2012;42(7):1459–69.
Malmberg K, Wargelius HL, Lichtenstein P, Oreland L, Larsson JO. ADHD and disruptive behavior scores – associations with MAO-a and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry. 2008;8:28. 23 Apr 2008.
Maron E, Lang A, Tasa G, et al. Associations between serotonin-related gene polymorphisms and panic disorder. Int J Neuropsychopharmacol. 2005;8(2):261–6.
May ME, Srour A, Hedges LK, et al. Monoamine oxidase a promoter gene associated with problem behavior in adults with intellectual/developmental disabilities. Am J Intellect Dev Disabil. 2009;114(4):269–73.
New York State Department of Health. Clinical practice guideline: report of the recommendations, autism/pervasive developmental disorders. In: Assessment and intervention for young children, (age 0–3 years). Albany: New York State Department of Health; 1999.
Passamonti L, Fera F, Magariello A, et al. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol Psychiatry. 2006;59(4):334–40.
Robins DL, Fein D, Barton ML, Green JA. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders. J Autism Dev Disord. 2001;31(2):131–44.
Roohi J, DeVincent CJ, Hatchwell E, Gadow KD. Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J Autism Dev Disord. 2009;39(1):67–74.
Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998;103(3):273–9.
Silva LM, Schalock M, Ayres R, Bunse C, Budden S. Qigong massage treatment for sensory and self-regulation problems in young children with autism: a randomized controlled trial. Am J Occup Ther. 2009;63(4):423–32.
Sjoberg RL, Ducci F, Barr CS, et al. A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology. 2008;33(2):425–30.
Sparrow SS, Cicchetti DV, Balla DA. Vineland-II survey forms manual. Minneapolis: Pearson; 2005.
Stone WL, McMahon CR, Henderson LM. Use of the screening tool for autism in two-year-olds (STAT) for children under 24 months: an exploratory study. Autism. 2008;12(5):557–73.
Warren Z, McPheeters ML, Sathe N, Foss-Feig JH, Glasser A, Veenstra-VanderWeele J. A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics. 2011;127(5):e1303–11.
Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2005;20(10):790–5.
Zwaigenbaum L, Tarnopolsky M. Two children with muscular dystrophies ascertained due to referral for diagnosis of autism. J Autism Dev Disord. 2003;33(2):193–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Cohen, I.L. (2014). PDD Behavior Inventories: Clinical and Research Applications to ASD. In: Patel, V., Preedy, V., Martin, C. (eds) Comprehensive Guide to Autism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4788-7_171
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4788-7_171
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4787-0
Online ISBN: 978-1-4614-4788-7
eBook Packages: Behavioral Science